APA (7th ed.) Citation

Montserrat, E., & Dreger, P. (2016). Treatment of chronic lymphocytic leukemia with del(17p)/TP53 mutation: Allogeneic hematopoietic stem cell transplantation or BCR-signaling inhibitors? Clinical lymphoma, myeloma & leukemia, 16, . https://doi.org/10.1016/j.clml.2016.02.013

Chicago Style (17th ed.) Citation

Montserrat, Emili, and Peter Dreger. "Treatment of Chronic Lymphocytic Leukemia with Del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-signaling Inhibitors?" Clinical Lymphoma, Myeloma & Leukemia 16 (2016). https://doi.org/10.1016/j.clml.2016.02.013.

MLA (9th ed.) Citation

Montserrat, Emili, and Peter Dreger. "Treatment of Chronic Lymphocytic Leukemia with Del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-signaling Inhibitors?" Clinical Lymphoma, Myeloma & Leukemia, vol. 16, 2016, https://doi.org/10.1016/j.clml.2016.02.013.